Prescription Drug Data Collection (RxDC) Reporting
You are leaving bbrown.com.
By accessing this link, you will be leaving Brown & Brown’s website and entering a site hosted by another party. Please be advised that you will no longer be subject to the privacy and security policies of Brown & Brown’s website. We encourage you to read and evaluate the privacy and security policies of the site you are entering, which may be different than those of Brown & Brown.
Under the No Surprises Act health care transparency provisions of the Consolidated Appropriations Act of 2020, group health plans and health issuers offering group health coverage (reporting entities) must complete annual reporting on prescription drug and health care enrollment, premiums and spending. This guide is intended to inform group health plans of their obligations under the RxDC reporting requirements.
Read the Full Summary